Navigation Links
Data on Xeomin® (incobotulinumtoxinA) in the Treatment of Blepharospasm to be Presented at the 115th Annual Meeting of the American Academy of Ophthalmology
Date:10/25/2011

GREENSBORO, N.C., Oct. 25, 2011 /PRNewswire/ -- Merz Pharmaceuticals, LLC, today announced that data from studies evaluating the dosing and adverse event profiles of Xeomin® (incobotulinumtoxinA), a botulinum toxin type A free from accessory proteins, in the treatment of blepharospasm (eyelid spasms) will be presented at the 115th Annual Meeting of the American Association of Ophthalmology (AAO) in Orlando, Fla.

These data include an extension of the Phase III, randomized, placebo-controlled, double-blind trial that assessed the safety and efficacy of XEOMIN in blepharospasm, which was recently published in the July 2011 issue of Movement Disorders, the official journal of the Movement Disorders Society. Findings from the Phase III trial demonstrate that XEOMIN was significantly more efficacious than placebo, as observed in the primary efficacy variable (change in Jankovic Rating Scale severity subscore six weeks following treatment), when administered in a single treatment session to patients with blepharospasm who were previously treated with onabotulinumtoxinA (Botox®).Blepharospasm, also referred to as benign essential blepharospasm, is a rare condition that possibly goes undiagnosed or misdiagnosed. Botulinum toxin is the only FDA-approved medication for the treatment of this condition. The U.S. Food and Drug Administration (FDA) approved XEOMIN in July 2010 for the treatment of blepharospasm in adults who have been previously treated with Botox®.

"XEOMIN studies led to clinically relevant reductions in the severity of symptoms such as excessive blinking and eyelid spasms," said lead author of the Movement Disorders publication Joseph Jankovic, MD, Professor of Neurology and Director of the Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas. "The results demonstrate the safety and efficacy of XEOMIN for the treatmen
'/>"/>

SOURCE Merz Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
2. Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S.
3. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
4. Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
5. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
6. New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinsons Disease And Movement Disorders (MDS)
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... and BARCELONA , October 31, ... (Multigate) was found to infringe two Australian patents of B. ... sale in Australia safety IV catheters ... in Federal Court of Australia proceeding ... http://www.austlii.edu.au/au/cases/cth/FCA/2014/1110.html . In the detailed judgment, Multigate ...
(Date:10/31/2014)... 2014 Migranade, Inc. announced today the new ... the 36 million U.S. migraine sufferers November, 2014. The ... the actual cause of migraines and not just the ... the source Migranade is assured to be a game ... is available at http://www.migranade.com and will soon ...
(Date:10/31/2014)... 30, 2014 Electronic prescribing or ... of prescription related information between prescriber, dispenser ... a physician and nurse practitioner to transmit ... error occurs during pharmacy operations. E-Prescribing system ... provides complete medical lists, conducts all security ...
Breaking Medicine Technology:B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2Game Changing Migraine Medication To Be Available November 2014 2E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2
... Clinical trials in which participants are randomly assigned to different ... conducted correctly, it,s widely accepted by the research community that ... But researchers at the University of Michigan hope to ... patients by investigating the impact of a class of innovative ...
... CRY ), an implantable biological medical device ... BioGlue Surgical Adhesive has received Shonin approval from the ... use in the repair of aortic dissections. ... in Japan for use in this subset of cardiac ...
Cached Medicine Technology:U-M Receives NIH, FDA Grant To Study Adaptive Clinical Trial Design 2CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 2CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 3CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 4CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 5
(Date:10/31/2014)... Fundraising support for fighting cancer prompts many creative events—the results ... Monday, November 10 in the paramedic garage at Soldiers ... Health (SH) employees and community members will gather together to ... new Cancer Center at SSMH. Three beauticians will be on ... and support to which many who have been touched by ...
(Date:10/31/2014)... Cambridge, Mass. Friday. October 31, 2014 — A ... California, Berkeley, and the University of California, Santa ... Institute (NCI) Cancer Genomics Cloud Pilot contracts with ... enable large-scale analysis of The Cancer Genome Atlas ... and the required computing resources in one cloud ...
(Date:10/31/2014)... 2014 At the start of 2014, ... escaping carbon monoxide poisoning in their homes. Now, as ... one family-owned, Missouri-based heating and cooling company is taking ... families start the home heating season with the assurance ... , Beginning Nov. 1, 2014, E and Q Heating ...
(Date:10/31/2014)... FRIDAY, Oct. 31, 2014 (HealthDay News) -- Sleep apnea may ... as where you parked your car or left your house ... with severe sleep apnea showed that this ability -- called ... eye movement (REM) sleep, even when other stages of sleep ... during which dreams typically occur. "We,ve shown for the ...
(Date:10/31/2014)... device to give cancer researchers an unprecedented microscopic look ... through the body, causing more than 90 percent of ... cells travel, the device could uncover new ways to ... university,s Whiting School of Engineering and its Institute for ... system recently in the journal Cancer Research . ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Soldiers + Sailors Memorial Hospital Razing Heads to Fight Cancer 2Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 2Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 3Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 3
... to Enable System Turn-On At Grand Opening and ... LodgeNet Healthcare, a division of LodgeNet Interactive ... leading provider of interactive patient television solutions, today ... is now serving patients at the Oklahoma Heart ...
... Continuing Care Retirement Community To Be Built on 59-Acre ... BRIARCLIFF MANOR, N.Y., May 19 ... Care Retirement Community (CCRC), announced today that it has ... State Department of Health. The Certificate of Authority, which ...
... Efficient Registration and Revenue Cycle Management ProcessesMOBILE, Ala., ... announced today that it has agreed to partner ... to an SSI product. SSI,s ClickON(R) PREVENT ( ... will be powered by Boston Software Systems, flagship ...
... MetroHealth Wall of Hope and Chris Evert Children,s Hospital ... CareTech Solutions, Inc. ( www.caretechsolutions.com ), ... provider for hospitals and health systems, has been honored ... the 2009 Aster Award ( www.AsterAwards.com ) ...
... 14 European groups, headed by Prof. Nils Brose of the ... million Euro, on behalf of the European Union, to study ... One of the research teams is headed by Prof. Kobi ... Ethology and has been awarded a grant of 600,000 Euro. ...
... Private Equity Firm Augments Team to Support Continued ... May 19 Water Street Healthcare Partners ... health care industry, announced today that it has expanded its ... The firm has appointed Peter Strothman to principal and ...
Cached Medicine News:Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 2Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 3Health News:The Club at Briarcliff Manor Receives Certificate of Authority from New York 2Health News:The Club at Briarcliff Manor Receives Certificate of Authority from New York 3Health News:SSI Group to Integrate Boston Software Systems' Boston WorkStation Into ClickON PREVENT 2Health News:SSI Group to Integrate Boston Software Systems' Boston WorkStation Into ClickON PREVENT 3Health News:CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence 2Health News:CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence 3Health News:Water Street Healthcare Partners Expands Team With Senior Investment Professionals 2Health News:Water Street Healthcare Partners Expands Team With Senior Investment Professionals 3
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
... PowerSuite™ holmium laser combines excellent cutting, ... virtually bloodless procedures. It is also ... gall bladder stones of all compositions, ... tool. Because its laser light is ...
... The OptiMumm™ smoke evacuator ... a complete smoke evacuation ... the AccuVac™ smoke evacuation ... system, and either the ...
Simple, stable knee positioning triangles for lower extremity surgery. The triangles are radiolucent, autoclavable, and use latex-free, sterile, disposable pads....
Medicine Products: